In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Looking Beyond The Deal In England

Executive Summary

Agreement of deals that promise better value for money and enhanced patient access to new treatments has become routine in England, but are they delivering?

You may also be interested in...



Novel Procurement Deal To Rid England Of Hepatitis C

NHS England has struck a “first of its kind” agreement with Gilead, AbbVie and MSD to try to eliminate hepatitis C under which the companies will seek out patients who do not yet know they have the virus.

Pressure Mounts For Agreement On New UK Voluntary Pricing Scheme

With the clock ticking on UK drug pricing negotiations, it is still unclear whether even high-level terms of a new voluntary deal will be agreed in time.

Industry Calls For Reform of England’s Unused Innovative Medicines Fund

The pharmaceutical industry says financial uncertainties are a key reason why the English Innovative Medicines Fund (IMF) – offering the potential for time-limited funding for promising non-cancer treatments where benefits are uncertain at launch - has still not been used a year after it was put in place. Industry wants the National Health Service to share the financial risk of taking part in the fund.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

IV146834

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel